| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10006800 | HBV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS30084720 | HIV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS30063823 | HIV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS30063824 | HIV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS30063825 | HIV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS20060150 | HPV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS20059200 | HPV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
| TVIS20018080 | HPV | ENSG00000145888.11 | protein_coding | GLRA1 | No | No | 2741 | P23415 Q14C71 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLRA1 |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0000433 |
| UniProt ID | P23415 |
| Regulation Type | |
| PubMed IDs | 16842826 |
| Citations | Chen Z, Dillon GH, Huang R: Identification of residues critical for Cu2+-mediated inhibition of glycine alpha1 receptors. Neuropharmacology. 2006 Sep;51(4):701-8. Epub 2006 Jul 12. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
